Opportunities and challenges for user-generated licensing models in gene-editing

Timo Minssen; Esther  Van Zimmeren; Jakob Wested

Opportunities and challenges for user-generated licensing models in gene-editing

Timo Minssen, Esther Van Zimmeren, Jakob Wested

Abstract

A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through the CRISPR patent jungle. But, there are many obstacles still in the way.

Original language	English
Publication date	Jul 2018
Publisher	Harvard Law School's Bill of Health blog
Publication status	Published - Jul 2018

Access to Document

http://blogs.harvard.edu/billofhealth/2018/07/14/could-user-generated-licensing-models-help-us-to-clear-a-path-through-the-crispr-patent-jungle/

Cite this

@misc{df18c1edab8d4ebfa0125001b33d9b7e,

title = "Opportunities and challenges for user-generated licensing models in gene-editing",

abstract = "A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through the CRISPR patent jungle. But, there are many obstacles still in the way.",

author = "Timo Minssen and {Van Zimmeren}, Esther and Jakob Wested",

year = "2018",

month = jul,

language = "English",

publisher = "Harvard Law School's Bill of Health blog",

type = "Other",

}

TY - ICOMM

T1 - Opportunities and challenges for user-generated licensing models in gene-editing

AU - Minssen, Timo

AU - Van Zimmeren, Esther

AU - Wested, Jakob

PY - 2018/7

Y1 - 2018/7

N2 - A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through the CRISPR patent jungle. But, there are many obstacles still in the way.

AB - A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through the CRISPR patent jungle. But, there are many obstacles still in the way.

M3 - Net publication - Internet publication

PB - Harvard Law School's Bill of Health blog

ER -

Opportunities and challenges for user-generated licensing models in gene-editing

Abstract

Access to Document

Fingerprint

Cite this